Do IV Fluids Lower Blood Sugar Levels?

Intravenous fluids without added sugar can lower blood sugar, and in diabetic emergencies, fluid resuscitation alone accounts for a meaningful portion of the initial drop in glucose before insulin even takes full effect. The mechanisms are straightforward: dilution of the blood, improved kidney filtration, and suppression of stress hormones that drive glucose up. But the picture gets more complicated depending on which fluid is hanging on the IV pole, because some solutions contain dextrose and will push blood sugar in the opposite direction.

How Plain IV Fluids Reduce Blood Sugar

When someone is dehydrated and hyperglycemic, their blood is essentially concentrated. Infusing a sugar-free crystalloid like normal saline or Ringer’s lactate adds volume to the bloodstream, which dilutes the glucose already circulating. This is hemodilution in its simplest form. Research on fluid kinetics shows that rising plasma glucose itself accelerates the rate at which infused fluid leaks from the bloodstream into surrounding tissues, meaning the body is already trying to redistribute that extra volume, but the net effect during the infusion is still an expansion of plasma volume that brings glucose concentrations down.¹

Dilution is only part of the story. Rehydration restores blood flow to the kidneys, allowing them to filter more glucose out of the blood and excrete it in the urine. It also lowers levels of counter-regulatory hormones, the stress-response chemicals like cortisol and aldosterone that normally tell the liver to dump more glucose into the bloodstream. IV rehydration has been shown to produce greater fluid retention and lower levels of these stress hormones compared with drinking fluids by mouth.² Finally, adequate hydration improves tissue perfusion, which helps insulin, whether the body’s own or an infusion, actually reach and act on cells. A pediatric review of diabetic ketoacidosis management summarized these three mechanisms neatly: hydration reduces hyperglycemia through decreased counter-regulatory hormones, enhanced renal glucose clearance, and augmented insulin sensitivity.³

These effects are real, but they are not a substitute for insulin in someone whose blood sugar is dangerously high. In diabetic ketoacidosis or hyperosmolar hyperglycemic syndrome, fluids are the first intervention, but insulin is what ultimately corrects the metabolic crisis. Think of the fluids as doing the initial heavy lifting while the insulin drip is being prepared and titrated.

Which Fluid Is on the IV Pole Matters a Lot

Not all IV fluids are interchangeable when it comes to blood sugar. The two most common sugar-free options are normal saline (0.9% sodium chloride) and balanced crystalloids like Ringer’s lactate. Both lower blood sugar in hyperglycemic patients, but they do so at different speeds. A randomized controlled trial in patients with diabetic ketoacidosis found that blood glucose dropped to about 14 mmol/L in roughly 300 minutes with normal saline, compared with about 410 minutes with Ringer’s lactate.⁴

That might seem like an open-and-shut win for normal saline, but the picture is more nuanced. When large volumes of normal saline are infused, the high chloride content can cause a specific type of metabolic acidosis that complicates recovery and may prolong ICU stays. Recent evidence and consensus reports have increasingly supported balanced crystalloids as an alternative, noting they are associated with faster resolution of ketoacidosis overall and shorter hospital stays.⁵ A 2024 consensus report from the American Diabetes Association recommended that clinicians can start with either isotonic saline or balanced crystalloids at a rate of roughly 500 to 1,000 mL per hour for the first two to four hours, then adjust based on the patient’s hydration status and sodium levels.⁶

The practical takeaway is that the choice between normal saline and a balanced solution is less about which one lowers blood sugar faster and more about the side-effect profile over the next several hours. Clinicians weigh availability, cost, and the patient’s kidney and heart function when deciding.

When IV Fluids Raise Blood Sugar Instead

Here is where many people get confused. Some IV solutions are designed to contain dextrose, a form of glucose. These are used deliberately in certain clinical situations, such as preventing low blood sugar once a patient’s glucose has already been brought down, or providing calories to someone who cannot eat. But if a dextrose-containing solution is given without a clear need, it can push blood sugar up, even in people who do not have diabetes.

A trial comparing Ringer’s lactate with a dextrose-saline solution in nondiabetic patients undergoing major surgery found that the dextrose group had significantly elevated blood glucose levels during and immediately after the operation.⁷ Another study looking at a similar comparison found that about 63% of patients receiving dextrose-containing maintenance fluid developed at least one episode of hyperglycemia (blood sugar at or above 150 mg/dL), compared with only 29% of those receiving Ringer’s lactate. The risk of becoming hyperglycemic was roughly doubled with dextrose, and patients in that group required significantly more insulin to keep glucose in a normal range.⁸

Surgery itself triggers a stress response that raises blood sugar even without any glucose being infused. Adding dextrose on top of that makes the spike worse. This is why anesthesiologists in most modern protocols default to sugar-free fluids during operations unless the patient’s blood sugar is already trending low.

Fluids in Diabetic Emergencies

Diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome are the two most common hyperglycemic crises. In both, the patient arrives severely dehydrated, sometimes having lost liters of fluid. The immediate priority is volume restoration, not insulin. Fluid resuscitation begins before or alongside insulin, and the fluids themselves start lowering glucose through the dilution, kidney clearance, and hormonal mechanisms described earlier.

Current guidelines recommend aggressive early rehydration, typically starting with isotonic saline or a balanced crystalloid at high flow rates for the first couple of hours, then tapering as the patient stabilizes.⁶ The insulin infusion is then calibrated to bring blood sugar down at a controlled rate. Once glucose falls to around 11 to 14 mmol/L (roughly 200 to 250 mg/dL), dextrose-containing fluids are typically added to the IV to prevent glucose from crashing too fast while insulin continues to clear the remaining ketones.³ That intentional switch from sugar-free to sugar-containing fluid is a deliberate balancing act: the insulin is still needed for the metabolic crisis, but the patient’s blood sugar has already come down enough that continuing without dextrose could cause dangerous hypoglycemia.

Why Speed of Correction Matters

Bringing blood sugar down too quickly during a hyperglycemic crisis can cause serious harm, particularly to the brain. Cerebral edema is a rare but feared complication, occurring in an estimated 0.7% to 1.0% of cases. It happens when blood osmolality (essentially, the concentration of dissolved particles in the blood) drops faster than brain cells can adjust. The rapid shift in concentration pulls water into brain tissue, causing it to swell.⁹ Animal studies have shown that the type of fluid matters here too: animals treated with isotonic fluid developed significantly less brain swelling than those given hypotonic fluid, because the isotonic solution avoids creating as steep an osmotic gradient.¹⁰

The question of exactly how fast to correct has been debated for years. A large observational study of ICU patients with diabetic ketoacidosis found that faster glucose correction, up to about 90 mg/dL per hour, was actually associated with lower mortality and fewer adverse neurologic events compared with very slow correction. The researchers suggested that an upper limit of about 5 mmol/L per hour for tonicity correction may be a reasonable safety boundary.¹¹ This challenges the older clinical instinct to go as slowly as possible. The emerging view is that moderate speed is both safe and beneficial, while excessively aggressive fluid resuscitation combined with rapid osmolality changes remains risky.

Potassium and the Hidden Electrolyte Danger

Blood sugar and potassium are linked in ways that matter during IV fluid therapy. When blood sugar is very high, potassium shifts out of cells and into the bloodstream, making serum potassium look normal or even elevated on a lab draw. But once insulin is given and glucose starts entering cells, potassium follows it back inside, and serum levels can plummet. This is dangerous: severely low potassium can cause cardiac arrhythmias.

Guidelines are clear that insulin should not be started if the patient’s serum potassium is below 3 mmol/L, because the insulin-driven intracellular shift would worsen the problem.¹² IV fluids themselves, especially when given rapidly, further dilute potassium in the blood. This is why aggressive potassium monitoring and replacement are standard alongside fluid resuscitation in any hyperglycemic crisis. If you have ever seen a patient with DKA hooked up to multiple IV bags, one of them is almost certainly a potassium-containing drip.

Hypoglycemia as a Treatment Complication

Overcorrecting blood sugar with IV insulin, especially without concurrent dextrose, can cause hypoglycemia, meaning glucose drops too low. This is a recognized risk even in settings where insulin is being used for reasons other than diabetes management. For example, IV insulin is sometimes given to treat dangerously high potassium levels. A study of emergency department patients receiving insulin for hyperkalemia found that lower baseline glucose, higher insulin doses, and lower doses of concurrent dextrose were all independently associated with developing hypoglycemia.¹³

The lesson extends to hyperglycemic crisis management. Once blood sugar approaches normal, the combination of fluid-driven dilution plus ongoing insulin creates a real risk of overshoot. This is precisely why protocols call for adding dextrose to the IV once glucose comes down to a certain threshold, and why frequent blood sugar checks (often every one to two hours during active treatment) are non-negotiable.

What About Routine Hospital IV Fluids?

Most people who receive IV fluids are not in a diabetic emergency. They are dehydrated from vomiting, recovering from surgery, or getting fluid alongside medications. In these situations, the blood-sugar-lowering effect of standard saline or Ringer’s lactate is modest and unlikely to be clinically meaningful for someone with normal glucose levels. Healthy kidneys regulate glucose tightly enough that simple hydration does not produce dangerous drops.

The surgical setting is the exception worth knowing about. The stress of surgery raises blood sugar even in people without diabetes, and the choice of IV fluid can either counteract or amplify that spike. As the studies above showed, dextrose-containing maintenance fluids roughly doubled the risk of intraoperative hyperglycemia in nondiabetic patients undergoing major surgery.⁸ If you are having surgery and are concerned about blood sugar, it is reasonable to ask your anesthesia team which maintenance fluid they plan to use, though in practice most hospitals have already moved away from dextrose-containing solutions as default surgical fluids.

Neonates and Pediatric Patients

Fluid management and blood sugar interact differently in newborns and children. Neonates have immature kidneys with a low filtration rate but also a high fluid intake relative to body weight. This combination means they are unlikely to develop significant glucose-driven urinary losses (osmotic diuresis) unless blood glucose climbs above roughly 12 mmol/L.¹⁴ In practical terms, the kidney-mediated glucose-lowering effect of IV fluids is blunted in very young infants compared with older children and adults.

Children with diabetic ketoacidosis are also more vulnerable to cerebral edema than adults, which is why pediatric protocols tend to use more conservative fluid replacement rates. The typical approach assumes a fluid deficit of around 6.5% to 8.5% of body weight and replaces it slowly over 24 to 48 hours.³ The goal is to bring blood sugar down without creating the kind of rapid osmolality swing that puts a child’s brain at risk.

A Long History of Fluids and Blood Sugar

The connection between IV fluids and blood sugar management is not a recent discovery. As early as 1938, physicians were publishing case reports in major medical journals about the combined use of insulin and salt solution to treat diabetic coma, recognizing that restoring blood volume and electrolyte balance was essential to “bring about a restoration of normal carbohydrate metabolism as indicated by a falling blood sugar.”¹⁵ What has changed in the decades since is not the fundamental insight that dehydrated patients with high blood sugar need fluids, but our understanding of exactly which fluids, how fast, and what to watch for while giving them. The debate between normal saline and balanced crystalloids, the recognition of cerebral edema risk, the awareness that dextrose-containing solutions can do harm when given carelessly, these are refinements layered onto a principle that clinicians have recognized for nearly a century.